Astera Labs, Inc.
ALAB
$58.96
$0.1750.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 396.29M | 305.71M | 229.55M | 163.39M | 115.79M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 396.29M | 305.71M | 229.55M | 163.39M | 115.79M |
| Cost of Revenue | 93.59M | 68.43M | 52.05M | 37.30M | 35.97M |
| Gross Profit | 302.70M | 237.28M | 177.50M | 126.09M | 79.83M |
| SG&A Expenses | 217.94M | 180.51M | 143.85M | 107.93M | 35.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 512.36M | 412.90M | 329.82M | 256.93M | 145.29M |
| Operating Income | -116.07M | -107.19M | -100.27M | -93.54M | -29.50M |
| Income Before Tax | -81.78M | -81.79M | -84.06M | -86.03M | -22.95M |
| Income Tax Expenses | 1.64M | 12.02M | 5.29M | 15.77M | 3.31M |
| Earnings from Continuing Operations | -83.42 | -93.81 | -89.34 | -101.80 | -26.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -83.42M | -93.81M | -89.34M | -101.80M | -26.26M |
| EBIT | -116.07M | -107.19M | -100.27M | -93.54M | -29.50M |
| EBITDA | -112.91M | -104.47M | -97.92M | -91.50M | -27.72M |
| EPS Basic | -1.71 | -1.50 | -1.53 | -2.03 | -0.75 |
| Normalized Basic EPS | -0.96 | -0.83 | -0.84 | -1.06 | -0.41 |
| EPS Diluted | -1.73 | -1.50 | -1.53 | -2.03 | -0.75 |
| Normalized Diluted EPS | -0.97 | -0.83 | -0.84 | -1.06 | -0.41 |
| Average Basic Shares Outstanding | 524.46M | 403.21M | 283.84M | 165.21M | 148.51M |
| Average Diluted Shares Outstanding | 542.12M | 403.21M | 283.84M | 165.21M | 148.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |